Healthcare Stocks Sliding Into Close; GW Pharma Spikes After Reporting Positive Results for MS Medication


Shutterstock photo

Top Healthcare Stocks

JNJ -0.40%

PFE -0.60%

ABT -1.45%

MRK +0.27%

AMGN -1.64%

Healthcare stocks are lower with the NYSE Healthcare Sector Index off 0.3% but with shares of healthcare companies in the S&P 500 falling nearly 0.7% as a group.

In company news, GW Pharmaceuticals ( GWPH ) is up 18.3% at $20.91, easing slightly from a new 52-week high of $22.70 that followed the the UK-based maker of cannabinoid prescription medicines Wednesday reporting data from new studies showing the long-term effectiveness of its Sativex drug candidate improving spasticity symptoms in patients with multiple sclerosis with no additional safety concerns identified in clinical practice.

The data is being presented Wednesday at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Copenhagen, Denmark.

Sativex also is being developed by GWPH for the treatment of cancer pain.

In other sector news,

(+) OMER, (+15.3%) Identifies six new lass A orphan G protein-coupled receptors linked to neurologic disorders, cardiovascular disease and cancer, paving the way for developing drugs that target those receptors.

(-) ZLCS, (-10.4%) Completes 1-for-6 reverse stock split at 12:01 a.m. today as part of efforts to lift share price well above $1 minimum needed for continued Nasdaq listing.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by